Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PX-866 in Recurrent or Metastatic Castration-Resistant Prostate Cancer
NCT01331083Phase 2Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Sep 2011
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sonolisib in prostate cancer (PCa), sponsored by Canadian Cancer Trials Group. Started Sep 2011; status: completed.
02
Drugs
sonolisib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01331083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01331083.